Neulasta (pegfilgrastim) is a brand-name drug that’s prescribed to treat radiation sickness and prevent certain complications of chemotherapy. Neulasta comes as an injectable solution. The dosage can ...
2016 and 2017 were difficult years for companies trying to win US Food and Drug Administration (FDA) approval for biosimilars of Amgen's blockbuster for treating side effects from chemotherapy. Last ...
In its second untitled letter of 2021, the US Food and Drug Administration’s (FDA) Office of Prescription Drug Promotion (OPDP) flagged issues with Amgen’s promotion of its biological product Neulasta ...
Amgen has received a letter from the FDA cautioning it against making misleading claims in advertising about its pegfilgrastim injector. The wording used in the advertisements claimed that the Onpro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results